| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 1,3 M € | -4.9% | 1,4 M € | -5.2% | 1,4 M € | -6.2% | 1,5 M € | +16.4% | 1,3 M € | +9.3% | 1,2 M € | -12.5% | 1,4 M € | -10.1% | 1,5 M € | +44.1% | 1,1 M € | -3.2% | 1,1 M € | +36.6% | 808,9 k € | +16.6% | 694,0 k € | -11.7% | 786,1 k € | -10.8% | 881,4 k € | -53.1% | 1,9 M € | -8.9% | 2,1 M € | -0.9% | 2,1 M € | +25.6% | 1,7 M € | +19.2% | 1,4 M € | |
| EBITDA | 346,8 k € | -29.1% | 489,4 k € | -34.6% | 748,3 k € | -21.3% | 950,2 k € | +45.0% | 655,2 k € | +9.8% | 596,6 k € | -20.8% | 752,9 k € | -15.6% | 892,5 k € | +106.8% | 431,6 k € | -17.7% | 524,1 k € | +76.7% | 296,6 k € | +121.3% | 134,1 k € | +153.3% | 52,9 k € | -83.9% | 329,6 k € | -64.9% | 938,9 k € | -28.0% | 1,3 M € | +1.7% | 1,3 M € | +17.1% | 1,1 M € | +22.3% | 895,2 k € | |
| Operating profit | 401,5 k € | -11.4% | 453,2 k € | -37.8% | 728,4 k € | -20.9% | 920,9 k € | +45.0% | 635,3 k € | +12.1% | 566,7 k € | -19.8% | 706,4 k € | -16.8% | 849,1 k € | +123.2% | 380,4 k € | -21.5% | 484,4 k € | +111.0% | 229,5 k € | +726.8% | 27,8 k € | +155.9% | -49,7 k € | -121.3% | 232,7 k € | -73.1% | 864,4 k € | -30.6% | 1,2 M € | +2.1% | 1,2 M € | +17.7% | 1,0 M € | +26.5% | 818,8 k € | |
| Profit/loss | 339,9 k € | -10.1% | 378,1 k € | -37.3% | 603,0 k € | +2.2% | 590,2 k € | +20.4% | 490,1 k € | -1.9% | 499,4 k € | -14.9% | 586,7 k € | -24.9% | 781,3 k € | +164.9% | 295,0 k € | -15.9% | 350,6 k € | +101.5% | 174,0 k € | +348.0% | 38,8 k € | +30.6% | 29,7 k € | -86.1% | 213,2 k € | -64.4% | 598,8 k € | -37.3% | 954,8 k € | +17.9% | 809,7 k € | +19.1% | 680,0 k € | +29.0% | 527,3 k € | |
| Equity | 2,5 M € | +16.0% | 2,1 M € | +21.6% | 1,8 M € | +52.5% | 1,1 M € | +105.7% | 558,3 k € | +9.4% | 510,4 k € | -44.0% | 911,0 k € | +16.2% | 784,2 k € | +20.1% | 652,9 k € | +17.0% | 558,0 k € | +37.0% | 407,4 k € | -23.6% | 533,4 k € | +7.9% | 494,6 k € | +6.4% | 464,9 k € | +84.7% | 251,7 k € | -88.8% | 2,3 M € | +32.7% | 1,7 M € | +31.8% | 1,3 M € | +59.4% | 808,3 k € | |
| Total assets | 3,5 M € | +16.9% | 3,0 M € | +16.0% | 2,6 M € | +53.6% | 1,7 M € | +1.2% | 1,7 M € | -9.5% | 1,8 M € | +0.0% | 1,8 M € | -2.8% | 1,9 M € | +43.7% | 1,3 M € | +12.5% | 1,2 M € | +45.0% | 810,1 k € | -6.0% | 862,0 k € | -11.3% | 971,9 k € | -12.1% | 1,1 M € | -34.9% | 1,7 M € | -40.1% | 2,8 M € | +22.7% | 2,3 M € | +36.8% | 1,7 M € | +21.2% | 1,4 M € | |
| Cash | 501,4 k € | -27.8% | 694,7 k € | -43.0% | 1,2 M € | +103.3% | 599,4 k € | +13.3% | 529,0 k € | -39.8% | 878,4 k € | +8.2% | 811,9 k € | -7.6% | 878,6 k € | +118.2% | 402,6 k € | -7.2% | 434,0 k € | +67.3% | 259,4 k € | +199.5% | 86,6 k € | -58.3% | 207,5 k € | +13.1% | 183,4 k € | -80.2% | 924,9 k € | -37.6% | 1,5 M € | +180.4% | 528,2 k € | +69.0% | 312,5 k € | -31.0% | 452,9 k € | |
| Debts | 1,0 M € | +26.1% | 827,7 k € | +7.4% | 770,7 k € | +60.4% | 480,5 k € | -54.7% | 1,1 M € | -17.3% | 1,3 M € | +45.5% | 880,5 k € | -17.0% | 1,1 M € | +73.9% | 610,0 k € | +8.6% | 561,9 k € | +65.2% | 340,2 k € | +39.5% | 244,0 k € | -40.9% | 412,6 k € | -20.5% | 518,9 k € | -60.8% | 1,3 M € | +205.0% | 433,7 k € | +5.7% | 410,3 k € | +9.8% | 373,6 k € | -35.6% | 580,1 k € | |
| Staff | 7,4 | 6,7 | 5,8 | 5,3 | 5,7 | 5,9 | 6,2 | 7 | 7,1 | 7,1 | 6,8 | 6,4 | 7,1 | 6,9 | 7,7 | 9,1 | 9,2 | 7,6 | 7,3 | |||||||||||||||||||
Public limited company · Antwerpen · incorporated on 28/01/2003 · 7,4 ETP
Public limited company profitable and well capitalised. Cash position declining (-27.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
BIOMEDICAL DIAGNOSTICS is a Public limited company incorporated in 2003. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Antwerpen. It employs on average 7,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette